| Bioequivalence Study of NPC-12 (Sirolimus) Granules and Tablets (NCT03765944) | Nobelpharma | 2018-12-05 |
| An Investigational Study to Evaluate Experimental Medication BMS-986165 Given as a Tablet and Solution in Healthy Male Participants (NCT03739788) | Bristol-Myers Squibb | 2018-12-05 |
| A Study of ALN-AAT02 in Healthy Participants and Participants With ZZ Type Alpha-1 Antitrypsin Deficiency Liver Disease (NCT03767829) | Alnylam Pharmaceuticals | 2018-12-05 |
| Vitamin C and Tyrosine Kinase Inhibitor in Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations (NCT03799094) | Clifford Hospital, Guangzhou, China | 2018-12-05 |
| Study to Measure Cerebrospinal Fluid Mutant Huntingtin Protein in Participants With Early Manifest Stage I or Stage II Huntington's Disease (NCT03664804) | Hoffmann-La Roche | 2018-12-05 |
| A Bioequivalence Study of Sunitinib Malate Capsules. (NCT05800106) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2018-12-04 |
| A Study to Evaluate the Safety and Pharmacokinetics of CNTX-6016 in Healthy Subjects (NCT04154501) | Centrexion Therapeutics | 2018-12-04 |
| A Single and Multiple Ascending Dose Study of CK-3773274 in Healthy Adult Subjects (NCT03767855) | Cytokinetics | 2018-12-04 |
| A Study of the Efficacy and Safety of Supaglutide in Healthy Participants (NCT03745885) | Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. | 2018-12-04 |
| A Study of CS1001 in Subjects with Advanced Solid Tumors (NCT03744403) | CStone Pharmaceuticals | 2018-12-04 |
| A Study to Evaluate the Safety of LAM561 Added to Standard of Care in Newly-diagnosed Glioblastoma Patients (NCT03867123) | Laminar Pharmaceuticals | 2018-12-04 |
| M6620 Plus Standard Treatment in Oesophageal and Other Cancer (NCT03641547) | University of Oxford | 2018-12-04 |
| Study to Evaluate DNL201 in Subjects With Parkinson's Disease (NCT03710707) | Denali Therapeutics Inc. | 2018-12-04 |
| Itacitinib in Advanced Hepatocellular Carcinoma (NCT04358185) | Imperial College London | 2018-12-03 |
| Phase I Study of AZD5363 + Olaparib + Durvalumab in Patients With Advanced or Metastatic Solid Tumor Malignancies (NCT03772561) | National University Hospital, Singapore | 2018-12-03 |
| Study on Single Administration and Dose Increment of Recombinant Human Serum Albumin/Erythrocyte Fusion Protein for Injection (NCT03786289) | Tianjin SinoBiotech Ltd. | 2018-12-03 |
| Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine Candidate in Healthy Adults (19-49 Years) (NCT06698198) | Sanofi Pasteur, a Sanofi Company | 2018-12-03 |
| A Study to Assess Bioquivalence Between a Novel Naproxen Sodium 275 mg Film-coated Tablet and Nalgesin Naproxen Sodium 275 mg Film-coated Tablet in Healthy Adult Volunteers (NCT03697889) | McNeil AB | 2018-12-03 |
| Reactogenicity, Safety and Immunogenicity of a LAIV А/17/Hong Kong/2017/75108 H7N9 Influenza Vaccine (NCT03739229) | Research Institute of Influenza, Russia | 2018-12-03 |
| A Randomized, Double-blinded, Placebo-controlled, Dose-escalation Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV Envelope Protein BG505 SOSIP.664 gp140 Vaccine, Adjuvanted, in Healthy, HIV-1 Uninfected Adults (NCT03699241) | International AIDS Vaccine Initiative | 2018-12-03 |
| PK and Bioavailability Comparison of Tofacitinib Between a Modified Release and The Immediate Release Formulation (NCT04403776) | Pfizer | 2018-12-03 |
| A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients (MATINS) (NCT03733990) | Faron Pharmaceuticals Ltd | 2018-12-03 |
| Short-term Clinical Study of CN128 in Thalassemia Patients (NCT03935633) | Hangzhou Zede Pharma-Tech Co., Ltd. | 2018-12-03 |
| A Safety and Tolerability Study of INCB053914 in Combination With INCB050465 in Diffuse Large B-Cell Lymphoma (NCT03688152) | Incyte Corporation | 2018-12-03 |
| A Phase 1/2a Study of PGT121, VRC07-523LS and PGDM1400 Monoclonal Antibodies in HIV-uninfected and HIV-infected Adults (NCT03721510) | International AIDS Vaccine Initiative | 2018-12-03 |
| STR + Anti PD-1 Therapy in Patients with Locally Advanced Unresectable Pancreatic Adenocarcinoma (NCT04098432) | University Hospital Hradec Kralove | 2018-12-03 |
| Reversal of Dual Antiplatelet Therapy With Cold Stored Platelets (NCT03787927) | Bloodworks | 2018-12-03 |
| Perioperative Intravesical Instilation of Hypertonic Saline Following Bladder Tumor Resection (NCT04147182) | Dan Leibovici | 2018-12-02 |
| Glycerol Phenylbutyrate Corrector Therapy For CF (Cystic Fibrosis) (NCT02323100) | National Jewish Health | 2018-12-02 |
| [KSR-001-P01]Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristic of KSR-001 (NCT05017870) | Kukje Pharma | 2018-12-02 |
| Drug-Drug Interaction Study of "CG100650" in Healthy Volunteers (NCT03775629) | CrystalGenomics, Inc. | 2018-12-01 |
| Epacadostat, Cladribine and Cytarabine (ECC) in AML (NCT03491579) | Insel Gruppe AG, University Hospital Bern | 2018-12-01 |
| Study of TG02 Citrate in Patients With Advanced Hepatocellular Carcinoma (NCT03738111) | Lee's Pharmaceutical Limited | 2018-12-01 |
| Giant Cell Arteritis Treatment With Ultra-short Glucocorticoids and Tocilizumab (NCT03745586) | Insel Gruppe AG, University Hospital Bern | 2018-12-01 |
| Effects of UCA-PSCs in Women With POF (NCT05138367) | Li-jun Ding | 2018-12-01 |
| Probiotics and Oxytocin Nasal Spray on Social Behaviors of Autism Spectrum Disorder (ASD) Children (NCT03337035) | Massachusetts General Hospital | 2018-12-01 |
| Effects of Chicken Extract and Collagen on Mobility (NCT04483024) | Shan May Yong | 2018-12-01 |
| Pharmacokinetic Study to Investigate the Bioavailability and Tolerability of 3 Oral Formulations of Sodium Thiosulfate (NCT02624479) | Insel Gruppe AG, University Hospital Bern | 2018-12-01 |
| Imaging of Advanced Tumours Using [131]I-IAZA (NCT03427320) | University of Alberta | 2018-12-01 |
| Ruxolitinib Plus LVP in Patients With R/R ETP-ALL (NCT03613428) | Sichuan University | 2018-12-01 |
| TCR-T Cell Immunotherapy of Lung Cancer and Other Solid Tumors (NCT03778814) | Second Affiliated Hospital of Guangzhou Medical University | 2018-12-01 |
| Multi-modality Imaging in Peritoneal Carcinomatosis of Colorectal Origin (NCT03699332) | Radboud University Medical Center | 2018-12-01 |
| PediCRaFT: Pediatric Crohn's Disease Fecal Transplant Trial (NCT03378167) | McMaster Children's Hospital | 2018-12-01 |
| A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies (NCT03999697) | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2018-12-01 |
| Safety and Efficacy Study of Loncastuximab Tesirine + Ibrutinib in Diffuse Large B-Cell or Mantle Cell Lymphoma (NCT03684694) | ADC Therapeutics S.A. | 2018-12-01 |
| Study of CD133KDEL Toxin in the Treatment for Solid Tumors (NCT02845414) | Masonic Cancer Center, University of Minnesota | 2018-12-01 |
| EPITHINK: Epigenetic Drug Treatment and Therapeutic Immunotherapy With NKR-2 (NCT03612739) | Celyad Oncology SA | 2018-12-01 |
| Yttrium-90 Radioembolization + Nivolumab for Liver + Extra-hepatic Metastases From Colorectal Cancer (NCT03307603) | Case Comprehensive Cancer Center | 2018-12-01 |
| Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in Singapore (NCT02569827) | Singapore General Hospital | 2018-12-01 |
| Efficacy of Bromocriptine For Fever Reduction in Acute Neurologic Injury (NCT03496545) | University of California, San Francisco | 2018-11-30 |
| A Study of ZN-c5 in Subjects With Breast Cancer (NCT03560531) | Zeno Alpha Inc. | 2018-11-30 |
| Cooling Anesthesia for Intravitreal Injection (NCT03732287) | Recens Medical, Inc. | 2018-11-30 |
| A Study in Healthy Volunteers and Patients With Mild Asthma to Investigate the Safety, Anti-inflammatory Effect of Inhaled AZD0449 (NCT03766399) | AstraZeneca | 2018-11-30 |
| Levoketoconazole Food Effect Study in Healthy Subjects (NCT03768388) | Cortendo AB | 2018-11-30 |
| Study of APL-1202 in Non-Muscle Invasive Bladder Cancer Patients Who Are Resistant to One Induction Course of BCG Treatment (NCT03672240) | Asieris Pharmaceutical Technologies Co., Ltd. | 2018-11-30 |
| Study to Evaluate Safety & Tolerability of AGI-134 in Solid Tumour (NCT03593226) | Agalimmune Ltd. | 2018-11-30 |
| Clinical Bioequivalence Study on Two Paracetamol Tablet Formulations (NCT03562780) | Fortune Pharmacal Co., Ltd. | 2018-11-30 |
| A Study on the Bioequivalence of Perindopril Tert-butylamine Tablets Taken on an Empty Stomach in Healthy Subjects (NCT04556058) | Sichuan Haisco Pharmaceutical Group Co., Ltd | 2018-11-29 |
| A Research Study of How Different Doses of a New Medicine NNC0148-0287 C (Insulin 287) Work on the Blood Sugar in People With Type 1 Diabetes When it is Taken Once a Week (NCT03723772) | Novo Nordisk A/S | 2018-11-29 |
| Imaging Activated Macrophages in the Lungs (NCT03494114) | Vanderbilt University Medical Center | 2018-11-29 |
| Trial of Indole-3-Carbinol and Silibinin (NCT03687073) | Masonic Cancer Center, University of Minnesota | 2018-11-29 |
| A Study of LY3454738 in Healthy Participants and Participants With Atopic Dermatitis (NCT03750643) | Eli Lilly and Company | 2018-11-29 |
| Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy Subjects (NCT03755778) | Enanta Pharmaceuticals, Inc | 2018-11-29 |
| Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response, Pilot Trial (NCT03367533) | Yale University | 2018-11-29 |
| Study of AC0058TA in Patients With Systemic Lupus Erythematosus (SLE) (NCT03878303) | ACEA Therapeutics, Inc. | 2018-11-28 |
| Compassionate Use Study of Tenalisib (RP6530) (NCT03711604) | Rhizen Pharmaceuticals SA | 2018-11-28 |
| TRimetazidine for acUte on Chronic Liver Failure STudy (NCT03737448) | Martin Pharmaceuticals | 2018-11-28 |
| Phase I Dose Escalation Study of Intravenously Administered S64315 in Combination With Orally Administered Venetoclax in Patients With Acute Myeloid Leukaemia. (NCT03672695) | Institut de Recherches Internationales Servier | 2018-11-28 |
| MG4101 Plus Rituximab Including Lymphodepletion in Patient With r/r NHL B-cell Origin (NCT03778619) | GC Cell Corporation | 2018-11-28 |
| alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells (NCT03692429) | Celyad Oncology SA | 2018-11-28 |
| Safety, Tolerability, and Pharmacokinetic Study of TRK-250 for Patients With Idiopathic Pulmonary Fibrosis (NCT03727802) | Toray Industries, Inc | 2018-11-28 |
| CD19-specific CAR T Cells With a Fully Human Binding Domain for CD19+ Leukemia or Lymphoma (NCT03684889) | Seattle Children's Hospital | 2018-11-28 |
| Ex-vivo Expanded γδ T-lymphocytes (OmnImmune®) in Patients With Acute Myeloid Leukaemia (AML) (NCT03790072) | TC Biopharm | 2018-11-27 |
| Vaccine-Based Immunotherapy Regimen For NSCLC and TNBC (NCT03674827) | Pfizer | 2018-11-27 |
| A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3474 Injection (NCT04144855) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2018-11-27 |
| A Phase I Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Anti-PD-1 Antibody (HLX10) in Combination With Avastin Biosimilar (HLX04) in Patients With Advanced Solid Tumors (NCT03757936) | Shanghai Henlius Biotech | 2018-11-27 |
| HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases (NCT03696030) | City of Hope Medical Center | 2018-11-27 |
| Savolitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors (NCT03598244) | National Cancer Institute (NCI) | 2018-11-27 |
| Study of Avelumab-M3814 Combinations (NCT03724890) | EMD Serono Research & Development Institute, Inc. | 2018-11-27 |
| Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies (NCT03739931) | ModernaTX, Inc. | 2018-11-27 |
| Evaluation of Safety of Repeated Doses of OP0201 Metered Dose Inhaler Compared to Placebo in Healthy Adult Volunteers (NCT03748758) | Novus Therapeutics, Inc | 2018-11-27 |
| Comparative Bioavailability Study of Human Chorionic Gonadotropin (hCG)-IBSA Versus a Marketed hCG Formulation (NCT03735030) | IBSA Institut Biochimique SA | 2018-11-27 |
| BOL-DP-o-04 in Patients With Low Back Pain and Sciatica (NCT04145310) | Breath of Life International Pharma Ltd | 2018-11-27 |
| A DDI Study of FDL169 and FDL176 in Healthy Subjects (NCT03756922) | Flatley Discovery Lab LLC | 2018-11-27 |
| Multiple Dose Ethnobridging PK Study in Healthy Subjects (NCT03750565) | Theravance Biopharma | 2018-11-27 |
| Single Dose Mass Balance Study With C14 - Labeled AAI101 in Healthy Male Volunteers (NCT03775668) | Allecra | 2018-11-27 |
| A Drug-drug Interaction Study to Investigate the Effect of Coadministration of EDP-305 on the PK of a Combined Oral Contraceptive in Healthy Female Subjects (NCT03783897) | Enanta Pharmaceuticals, Inc | 2018-11-27 |
| A Phase 1 Study to Evaluate the Safety and Tolerability of CBL-514 Injection on Convexity or Fullness of Abdominal Subcutaneous Fat in Healthy Volunteers (NCT04699669) | Caliway Biopharmaceuticals Co., Ltd. | 2018-11-27 |
| SINGaporean Program Performed With an eXPANsion Medical Device (SingXpand) (NCT04198883) | CellProthera | 2018-11-27 |
| Staccato Apomorphine Single and Multi Dose PK (NCT03822364) | Alexza Pharmaceuticals, Inc. | 2018-11-26 |
| Gemcitabine, Bendamustine, and Nivolumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (NCT03739619) | Emory University | 2018-11-26 |
| A Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE) (NCT03724916) | Millennium Pharmaceuticals, Inc. | 2018-11-26 |
| Efficacy of Lidocaine Gel Enema After Endoscopic Hemorrhoid Band Ligation for Relief of Post Procedural Pain (NCT03797703) | Wake Forest University Health Sciences | 2018-11-26 |
| PVSRIPO for Patients With Unresectable Melanoma (NCT03712358) | Istari Oncology, Inc. | 2018-11-26 |
| Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Lenacapavir Administered Subcutaneously in Human Immunodeficiency Virus (HIV) -1 Infected Adults (NCT03739866) | Gilead Sciences | 2018-11-26 |
| Multi-Center Study of GSK2857916 in Combination With Pomalidomide and Dex (NCT03715478) | Canadian Myeloma Research Group | 2018-11-26 |
| MB-CART19.1 r/r CD19+ B-cell Malignancies (BCM) (NCT03853616) | Miltenyi Biomedicine GmbH | 2018-11-26 |
| Elucidation of the Mechanisms and Effects of Certain Anesthetic Interventions on Digestive Cancer Patients Subjected to Surgery (NCT04162535) | Iuliu Hatieganu University of Medicine and Pharmacy | 2018-11-26 |
| GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors (NCT03693612) | GlaxoSmithKline | 2018-11-26 |
| Phase 1, Safety and Bronchopulmonary PK Study in Healthy Volunteers (NCT03691584) | Tetraphase Pharmaceuticals, Inc | 2018-11-26 |